Review
Open access
Sep 2026
Targeting Glycolytic Reprogramming in Gastric Cancer: Navigating the Translational Maze from Mechanism to Clinic
Gastric cancer (GC) remains one of the leading causes of cancer-related mortality worldwide. Among its defining hallmarks, metabolic reprogramming, particularly aerobic glycolysis (the Warburg effect), emerged as a central driver of tumor progression, therapeutic resistance, and immune evasion. Over the past decades, s...
Gui-Bing Meng, Yu-Lin Li, Li-Min Gan et al.
· Cells · 0 citations